Low Hemoglobin, IDH2, Indicative of Poor Survival in MDS
A retrospective study published in Leukemia and Lymphoma suggested the presence of predictive biomarkers for outcomes myelodysplastic syndrome/myeloproliferative(MDS/MPN) neoplasms with PCN, as well as gave insights into the clinical features of …